State Street Corporation (NASDAQ: VRDN) discloses 5.5% Viridian Therapeutics ownership

Rhea-AI Filing Summary

State Street Corporation reported a significant ownership position in Viridian Therapeutics, Inc.6,124,976 shares of Viridian common stock, representing 5.5% of the class.

All voting and dispositive authority over these shares is reported as shared, with 5,894,254 shares subject to shared voting power and 6,124,976 shares subject to shared dispositive power, and no shares under sole power. The position is held through subsidiaries including SSGA Funds Management, Inc. and several State Street Global Advisors entities.

Key Figures

Beneficially owned shares: 6,124,976 shares Percent of class: 5.5% Shared voting power: 5,894,254 shares +3 more

6 metrics

Beneficially owned shares 6,124,976 shares Common stock beneficially owned by State Street Corporation

Percent of class 5.5% Percentage of Viridian Therapeutics common stock class held

Shared voting power 5,894,254 shares Shares over which State Street has shared power to vote

Shared dispositive power 6,124,976 shares Shares over which State Street has shared power to dispose

Sole voting power 0 shares Shares with sole power to vote or direct the vote

Sole dispositive power 0 shares Shares with sole power to dispose or direct disposition

Key Terms

beneficially owned, shared voting power, shared dispositive power, Investment Company Act of 1940, +1 more

5 terms

beneficially owned financial

"Amount beneficially owned: 6124976.00"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

shared voting power financial

"Shared power to vote or to direct the vote: 5,894,254"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power financial

"Shared power to dispose or to direct the disposition of: 6,124,976"

Investment Company Act of 1940 regulatory

"shareholders of an investment company registered under the Investment Company Act of 1940"

A U.S. federal law that sets the rulebook for pooled investment vehicles such as mutual funds, exchange-traded funds and similar money managers, requiring them to register with regulators, disclose holdings and fees, limit conflicts of interest, and follow governance standards. It matters to investors because these protections and transparency rules act like a referee and scoreboard, helping people compare funds, trust that managers follow fair practices, and spot hidden costs or risks.

investment adviser (IA) financial

"SSGA FUNDS MANAGEMENT, INC. (IA);STATE STREET GLOBAL ADVISORS"

An investment adviser (IA) is a person or firm that provides personalized guidance on buying, selling, or holding investments and often manages client portfolios for a fee. Investors should care because an IA has a legal duty to act in the client's best interest—think of them as a navigator who plans and steers your financial journey—so their advice, fee structure and potential conflicts can directly affect returns and financial risk.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 11:13 AM Accepted by SEC EDGAR 08/07/2026 - 11:12 AM Learn about SEC filing dates

FAQ

How many VRDN shares does State Street Corporation report owning?

State Street Corporation reports beneficial ownership of 6,124,976 shares of Viridian Therapeutics, Inc. (VRDN) common stock. This stake is held with shared dispositive power through various State Street Global Advisors entities.

What percentage of Viridian Therapeutics (VRDN) does State Street own?

State Street Corporation reports owning 5.5% of the VRDN common stock class. This percentage is based on 6,124,976 beneficially owned shares, giving State Street a notable institutional position in the company.

Does State Street have sole or shared voting power over its VRDN shares?

State Street reports 0 shares with sole voting power and 5,894,254 shares with shared voting power in VRDN. All reported voting authority is therefore shared, not individually controlled by State Street alone.

Which State Street subsidiaries are associated with the VRDN holdings?

The VRDN holdings are associated with SSGA Funds Management, Inc. and several State Street Global Advisors entities, including Europe Limited, Limited, Trust Company, and Ltd., each classified as an investment adviser (IA).

Does any other party have rights to proceeds from State Street’s VRDN shares?

The filing states “NOT APPLICABLE” regarding others’ rights to dividends or sale proceeds for the VRDN shares. It does not identify any specific third party with more than 5% economic interest in this position.

What class of Viridian Therapeutics securities does State Street hold?

State Street’s reported position is in Viridian Therapeutics’ common stock, identified by CUSIP 92790C104. The Schedule 13G covers only this class of securities, not preferred stock or other instruments.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

VIRIDIAN THERAPEUTICS INC

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

92790C104

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 92790C104

1

Names of Reporting Persons

STATE STREET CORPORATION

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

MASSACHUSETTS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 5,894,254.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 6,124,976.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

6,124,976.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.5 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: VIRIDIAN THERAPEUTICS INC
(b)	Address of issuer's principal executive offices: 6200 LOOKOUT ROAD, BOULDER, COLORADO, 80301
Item 2.
(a)	Name of person filing: STATE STREET CORPORATION;
(b)	Address or principal business office or, if none, residence: ONE CONGRESS STREET, SUITE 1, BOSTON MA 02114, UNITED STATES
(c)	Citizenship: MA
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP Number(s): 92790C104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 6124976.00
(b)	Percent of class: 5.5 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 5,894,254
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 6,124,976
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. NOT APPLICABLE
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. SSGA FUNDS MANAGEMENT, INC. (IA);STATE STREET GLOBAL ADVISORS EUROPE LIMITED (IA);STATE STREET GLOBAL ADVISORS LIMITED (IA);STATE STREET GLOBAL ADVISORS TRUST COMPANY (IA);STATE STREET GLOBAL ADVISORS, LTD. (IA);
Item 8.	Identification and Classification of Members of the Group.
	If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(K), so indicate under Item 3(k) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group. NOT APPLICABLE
Item 9.	Notice of Dissolution of Group.
	Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5. NOT APPLICABLE

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

STATE STREET CORPORATION

Signature:	ELIZABETH SCHAEFER
Name/Title:	SENIOR VICE PRESIDENT, CHIEF ACCOUNTING OFFICER
Date:	08/07/2026